| Ytd | 65679.57% | |
| 1y | 65679.57% |
| Open | 24.59 | Prev Close | 24.63 | Low | 24.15 | High | 24.97 | Mkt Cap | 1.32B |
| Vol | 55.36K | Avg Vol | 347.06K | EPS | -18.57 | P/E | -1.33 | Forward P/E | -14.39 |
| Beta | N/A | Short Ratio | 7.27 | Inst. Own | 74.28% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-11 | 50-d Avg | 23.19 | 200-d Avg | 20.74 | 1yr Est | 33.88 |
AKTS News
JP Morgan analyst Jessica Fye maintains Aktis Oncology (NASDAQ:AKTS) with a Overweight and raises
US stocks were mixed, Nasdaq fell 1%. DigitalOcean shares rose after strong revenue growth and earni
Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-m
Gainers Innovative Eyewear (NASDAQ:LUCY) stock moved upwards by 95.4% to $1.49 during Monday's
Top Wall Street analysts changed outlook on top names. For all changes, including upgrades/downgrade
U.S. stocks were mixed, with the Dow Jones gaining 100 points. Rezolve AI (RZLV) jumped 11.9%, and o
Aktis Oncology trades at a $1.1B market cap with $540M cash, pricing its pipeline and Eli Lilly coll
BOSTON, May 27, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clini
BOSTON, May 21, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company),
This clinical-stage biotech develops targeted radiopharmaceutical therapies for cancer using a propr
BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company),
BOSTON, May 06, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clini
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company),
Top analysts change outlook on Hyperfine Inc, Legence, and Aktis Oncology with Buy/Outperform rating
Aktis Oncology is initiated with a "Buy" rating, driven by its innovative miniprotein radioconjugate
The mean of analysts' price targets for Aktis (AKTS) points to a 74.7% upside in the stock. While th
BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a cli
BOSTON, March 30, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a cli
Top analysts change outlook on top names. See all analyst rating changes on Benzinga's analyst r
BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS), a clinical-stage oncol
BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS), a clinical-stage oncol
In the past week, a beneficial owner has continued to build a stake in insurance giant W.R.
Guru Stock PicksAndreas Halvorsen has made the following transactions:Add in RRX by 5.71%Stock News
For speculative investors, the start of each year is always a good time to revisit an initial public
Stock News Saks Global files Chapter 11: Saks Global (private) sought Chapter 11 protection, citing
On Friday morning, 446 companies hit new 52-week lows.
During Wednesday's trading, 517 companies set new 52-week lows.
On Tuesday, 838 companies hit new 52-week lows.
On Thursday, 930 stocks hit new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Gainers
US stocks recorded gains on the final trading day of January, with the Nasdaq Composite surging more
US stocks gained on the final trading day of January, with the Nasdaq Composite surging above the 14
Gainers FGI Industries Ltd. (NASDAQ: FGI) shares jumped 42.4% to $5.37 after surging 19% on Frida
During Wednesday's morning trading, 254 companies set new 52-week highs.
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Highs On Wednesday
Stocks Which Set New 52-Week Low Friday, October 26th
Stocks Which Set New 52-Week Low Yesterday, October 23rd